Diurnal variations in endocrine and psychological responses to 0.2 mg/kg naloxone administration in patients with major depressive disorder and matched controls

Journal of Affective Disorders

Volumn 57, Issue 1-3, 2000, Pages 37-47

  Martin Del Campo A F ^a   Dowson, J H ^b   Herbert, J ^b   Paykel, E S ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Depression; Diurnal variations; Endocrine; Humans; Mood; Naloxone

Indexed keywords

CORTICOTROPIN; ENDORPHIN; HYDROCORTISONE; LUTEINIZING HORMONE; NALOXONE;

ADULT; ARTICLE; BOLUS INJECTION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CROSSOVER PROCEDURE; DEPRESSION; DYSPHORIA; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LUTEINIZING HORMONE BLOOD LEVEL; MOOD; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE;

ADRENOCORTICOTROPIC HORMONE; ADULT; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LUTEINIZING HORMONE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID PEPTIDES; PERSONALITY INVENTORY; PITUITARY-ADRENAL SYSTEM; SINGLE-BLIND METHOD;

EID: 0034598433     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(99)00070-1     Document Type: Article

References (26)

1. Amsterdam J.D., Maislin G., Winokur A., Kling M., Gold P. Pituitary and adreno-cortical responses to the ovine cortiocotropin releasing hormone in depressed patients and healthy volunteers. Arch. Gen. Psychiatry. 44:1987;775-781.
2. Babino T.H., Hsueh A.J.W. Direct inhibitory effect of glucocorticoids upon testicular leteinizing hormone receptor and steroidogenesis in vivo and in vitro. Endocrinology. 108:1981;2142.
3. Byck R. Peptides transmitters: a unifying hypothesis for euphoria, respiration, sleep, and the action of lithium. Lancet. July 10:1976;72-73.
4. Carrol B.J., Curtis G.C., Mendels J. Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. Arch. Gen. Psychiatry. 33:1976;1051-1058.
5. Carrol B.J., Greden J.F., Haskett R., Feinberg M., Albala A.A., Martin F.I.R., Rubin R.T., Heath B., Sharp P.T., McLeod W.L., McLeod M.F. Neurotransmitter studies of neuroendocrine pathology in depression. Acta Psychiatr. Scand. 61:(Suppl. 280):1980;183-199.
6. Charlton B.G., Ferrier I.N. Hypothalamo-pituitary-adrenal axis abnormalities in depression: a review and a model. Psychol. Med. 19:1989;331-336.
7. Cohen M.R., Cohen R.M., Pickar D., Sunderland T., Mueller I.I.I.E.A., Murphy D.L. High dose naloxone in depression. Biol. Psychiatry. 19:1984;825-832.
8. Cohen M.R., Cohen R.M., Pickar D., Weingartner H., Murphy D.L. High-dose naloxone infusions in normals. Arch. Gen. Psychiatry. 40:1983;613-619.
9. Davis G.C., Buchsbaum M.S., Bunney W.E. Naloxone decreases diurnal variation in pain sensitivity and somatosensory evoked potentials. Life Sci. 23:1978;1449-1460.
10. Davis G.C., Bunney W.E., Buchsbaum M.S., De Fraites G., Duncan W., Gillin J.C., van Kammen D.P., Kleinman J., Murphy D.L., Post R.M., Reus V., Wyatt R.J. Use of narcotic antagonists to study the role of endorphins in normal and psychiatric patients. Usdin E., et al. Endorphins in Mental Health Research. 1979;393-406 Macmillan, London.
11. Emrich H.M., Cording C., Piree S., Kolling A., Moller H.J., von Zerssen D., Herz A. Actions of naloxone in different types of psychoses. Usdin E., et al. Endorphins in Mental Health Research. 1979;393-406 Macmillan, London.
12. Eysenck H.J., Eysenck S.B.G. Manual of the Eysenck Personality Questionnaire. 1975;Hodder and Stoughton, London.
13. Fink M., Simeon J., Itil T.M., Freedman A.M. Clinical antidepressant activity of cyclazocine - a narcotic antagonist. Clin. Pharmacol. Ther. 11:1970;41-48.
14. Grevert P., Albert L.H., Inturrisi C.E., Goldstein A. Effects of eight-hour naloxone infusions on human subjects. Biol. Psychiatry. 18:1983;1375-1392.
15. Grossman A., Gaillard R.C., McCartney P., Rees L.H., Besser G.M. Opiate modulation of the pituitary-adrenal axis, effects of stress and circadian rhythm. Clin. Endocrinol. 17:1982;279-286.
16. Judd L., Risch S., Parker D., Janowsky D., Segal D., Leighton Y., Huey L. Blunted prolactin response: a neuroendocrine abnormality manifested by depressed patients. Arch. Gen. Psychiatry. 39:1982;1413-1416.
17. Martín del Campo A.F., Dowson J., Herbert J., Paykel E. Effects of naloxone on diurnal rhythms in mood and endocrine function, a dose/response study in man. Psychopharmacology. 114:1994;583-590.
18. Martín del Campo A.F., McMurray R.G., Besser G.M., Grossman A. Effect of 12-hour infusion of naloxone on mood and cognition in normal male volunteers. Biol. Psychiatry. 32:1992;344-353.
19. McNair D., Lorr M., Droppleman L. EITS Manual, the Profile of Mood States. 1971;Educational and Industrial Testing Service, San Diego, CA.
20. Naber D., Jungkunz G. Opiate receptor sensitivity in depressed patients before and after clomipramine treatment. J. Affect. Disord. 11:1986;59-62.
21. Paykel E.S. The clinical interview for depression. Development, reliability and validity. J. Affect. Disord. 9:1985;85-96.
22. Pickar D., Cohen M.R., Naber D., Cohen R.M. Clinical studies of the endogenous opioid system. Biol. Psychiatry. 17:1982;1243-1276.
23. Sakakura M., Takebe K., Nakagawa S. Inhibition of luteinising hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects. J. Clin. Endocrinol. Metab. 40:1975;774.
24. Spitzer R.L., Endicot J.E., Robbins E. Research Diagnostic Criteria For A Selected Group of Functional Disorders. 3rd ed. 1978;Biometrics Research, New York State Psychiatric Institute, New York.
25. Terenius L., Wahlström A., Ågren H. Naloxone (Narcan) treatment in depression: clinical observations and effects on CSF endorphins and monoamine metabolites. Psychopharmacology. 54:1977;31-33.
26. Zis A.P., Haskett R.F., Albala A.A., Carroll B.J., Lohr N.E. Opioid regulation of hypothalamic-pituitary-adrenal function in depression. Arch. Gen. Psychiatry. 42:1985;383-386.